TNDM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TNDM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tandem Diabetes Care's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $-0.0 Mil.
Tandem Diabetes Care's quarterly Other Stockholders Equity declined from Mar. 2024 ($-0.0 Mil) to Jun. 2024 ($-0.0 Mil) but then increased from Jun. 2024 ($-0.0 Mil) to Sep. 2024 ($-0.0 Mil).
Tandem Diabetes Care's annual Other Stockholders Equity increased from Dec. 2021 ($-0.0 Mil) to Dec. 2022 ($0.0 Mil) but then declined from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($-0.0 Mil).
The historical data trend for Tandem Diabetes Care's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Stockholders Equity | Get a 7-Day Free Trial | - | - | - | - | - |
Tandem Diabetes Care Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Stockholders Equity | Get a 7-Day Free Trial | - | - | - | - | - |
Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity
Thank you for viewing the detailed overview of Tandem Diabetes Care's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Kim D Blickenstaff | director, officer: PRESIDENT AND CEO | C/O MEDIVATION, INC., 201 SPEAR STREET, 3RD FLOOR, SAN FRANCISCO CA 94105 |
Dick Allen | director | 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
Shannon Marie Hansen | officer: SVP & General Counsel | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Leigh Vosseller | officer: Senior Vice President and CFO | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Kathleen Mcgroddy-goetz | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Peyton R Howell | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
David B Berger | officer: GENERAL COUNSEL | 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
Malagueira Joao Paulo Falcao | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Myoungil Cha | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
John F Sheridan | officer: EXECUTIVE VP AND COO | C/O TANDEM DIABETES CARE, INC., 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
Christopher J Twomey | director | 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121 |
Rebecca B Robertson | director | ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104 |
James Leal | officer: SVP, Operations | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Elizabeth Anne Gasser | officer: EVP, Chief Strategy Officer | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Susan Morrison | officer: CAO | 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
From GuruFocus
By GuruFocus News • 10-28-2024
By GuruFocus News • 10-21-2024
By GuruFocus News • 10-09-2024
By Business Wire • 08-19-2024
By GuruFocus News • 10-17-2024
By Business Wire • 09-19-2024
By GuruFocus Research • 09-23-2024
By GuruFocus Research • 09-10-2024
By Business Wire • 11-06-2024
By GuruFocus News • 11-06-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.